336 related articles for article (PubMed ID: 26019190)
1. Effect of comorbidity on mortality in multiple sclerosis.
Marrie RA; Elliott L; Marriott J; Cossoy M; Blanchard J; Leung S; Yu N
Neurology; 2015 Jul; 85(3):240-7. PubMed ID: 26019190
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity increases the risk of hospitalizations in multiple sclerosis.
Marrie RA; Elliott L; Marriott J; Cossoy M; Tennakoon A; Yu N
Neurology; 2015 Jan; 84(4):350-8. PubMed ID: 25540309
[TBL] [Abstract][Full Text] [Related]
3. Cancer Incidence and Mortality Rates in Multiple Sclerosis: A Matched Cohort Study.
Marrie RA; Maxwell C; Mahar A; Ekuma O; McClintock C; Seitz D; Webber C; Groome PA
Neurology; 2021 Jan; 96(4):e501-e512. PubMed ID: 33239364
[TBL] [Abstract][Full Text] [Related]
4. Intensive care unit admission in multiple sclerosis: increased incidence and increased mortality.
Marrie RA; Bernstein CN; Peschken CA; Hitchon CA; Chen H; Fransoo R; Garland A
Neurology; 2014 Jun; 82(23):2112-9. PubMed ID: 24808019
[TBL] [Abstract][Full Text] [Related]
5. Common comorbidities and survival in MS: Risk for stroke, type 1 diabetes and infections.
Murtonen A; Kurki S; Hänninen K; Soilu-Hänninen M; Sumelahti ML
Mult Scler Relat Disord; 2018 Jan; 19():109-114. PubMed ID: 29190573
[TBL] [Abstract][Full Text] [Related]
6. Breast Cancer Survival in Multiple Sclerosis: A Matched Cohort Study.
Marrie RA; Maxwell C; Mahar A; Ekuma O; McClintock C; Seitz D; Groome P
Neurology; 2021 Jul; 97(1):e13-e22. PubMed ID: 34011575
[TBL] [Abstract][Full Text] [Related]
7. Psychiatric comorbidity increases mortality in immune-mediated inflammatory diseases.
Marrie RA; Walld R; Bolton JM; Sareen J; Patten SB; Singer A; Lix LM; Hitchon CA; El-Gabalawy R; Katz A; Fisk JD; Bernstein CN;
Gen Hosp Psychiatry; 2018; 53():65-72. PubMed ID: 29929117
[TBL] [Abstract][Full Text] [Related]
8. Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis.
Zhang T; Tremlett H; Leung S; Zhu F; Kingwell E; Fisk JD; Bhan V; Campbell TL; Stadnyk K; Yu BN; Marrie RA;
Neurology; 2016 Apr; 86(14):1287-1295. PubMed ID: 26944268
[TBL] [Abstract][Full Text] [Related]
9. Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database.
Capkun G; Dahlke F; Lahoz R; Nordstrom B; Tilson HH; Cutter G; Bischof D; Moore A; Simeone J; Fraeman K; Bancken F; Geissbühler Y; Wagner M; Cohan S
Mult Scler Relat Disord; 2015 Nov; 4(6):546-54. PubMed ID: 26590661
[TBL] [Abstract][Full Text] [Related]
10. The utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study.
Marrie RA; Yu BN; Leung S; Elliott L; Caetano P; Warren S; Wolfson C; Patten SB; Svenson LW; Tremlett H; Fisk J; Blanchard JF;
Neuroepidemiology; 2013; 40(2):85-92. PubMed ID: 23095571
[TBL] [Abstract][Full Text] [Related]
11. Physical comorbidities increase the risk of psychiatric comorbidity in immune-mediated inflammatory disease.
Marrie RA; Walld R; Bolton JM; Sareen J; Walker JR; Patten SB; Singer A; Lix LM; Hitchon CA; El-Gabalawy R; Katz A; Fisk JD; Bernstein CN;
Gen Hosp Psychiatry; 2018; 51():71-78. PubMed ID: 29353127
[TBL] [Abstract][Full Text] [Related]
12. Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia.
Marrie RA; Yu BN; Leung S; Elliott L; Caetano P; Warren S; Wolfson C; Patten SB; Svenson LW; Tremlett H; Fisk J; Blanchard JF;
Mult Scler; 2012 Sep; 18(9):1310-9. PubMed ID: 22328682
[TBL] [Abstract][Full Text] [Related]
13. Traditional risk factors may not explain increased incidence of myocardial infarction in MS.
Marrie RA; Garland A; Schaffer SA; Fransoo R; Leung S; Yogendran M; Kingwell E; Tremlett H
Neurology; 2019 Apr; 92(14):e1624-e1633. PubMed ID: 30842298
[TBL] [Abstract][Full Text] [Related]
14. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada.
Kingwell E; van der Kop M; Zhao Y; Shirani A; Zhu F; Oger J; Tremlett H
J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):61-6. PubMed ID: 21865212
[TBL] [Abstract][Full Text] [Related]
15. Comorbidity in multiple sclerosis: its temporal relationships with disease onset and dose effect on mortality.
Chou IJ; Kuo CF; Tanasescu R; Tench CR; Tiley CG; Constantinescu CS; Whitehouse WP
Eur J Neurol; 2020 Jan; 27(1):105-112. PubMed ID: 31309645
[TBL] [Abstract][Full Text] [Related]
16. Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study.
Lalmohamed A; Bazelier MT; Van Staa TP; Uitdehaag BM; Leufkens HG; De Boer A; De Vries F
Eur J Neurol; 2012 Jul; 19(7):1007-14. PubMed ID: 22353360
[TBL] [Abstract][Full Text] [Related]
17. Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality.
Thormann A; Sørensen PS; Koch-Henriksen N; Laursen B; Magyari M
Neurology; 2017 Oct; 89(16):1668-1675. PubMed ID: 28931645
[TBL] [Abstract][Full Text] [Related]
18. Causes of death among persons with multiple sclerosis.
Cutter GR; Zimmerman J; Salter AR; Knappertz V; Suarez G; Waterbor J; Howard VJ; Marrie RA
Mult Scler Relat Disord; 2015 Sep; 4(5):484-490. PubMed ID: 26346799
[TBL] [Abstract][Full Text] [Related]
19. Health care utilization before and after intensive care unit admission in multiple sclerosis.
Marrie RA; Bernstein CN; Peschken CA; Hitchon CA; Chen H; Fransoo R; Garland A
Mult Scler Relat Disord; 2015 Jul; 4(4):296-303. PubMed ID: 26195046
[TBL] [Abstract][Full Text] [Related]
20. Mortality trends for multiple sclerosis patients in Sweden from 1968 to 2012.
Burkill S; Montgomery S; Hajiebrahimi M; Hillert J; Olsson T; Bahmanyar S
Neurology; 2017 Aug; 89(6):555-562. PubMed ID: 28687718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
